Skip to content
★ Sign in to follow
程

程增江

Board Director
Director
博瑞医药
Total declarations
1
Company
1
▲ Purchases (1 ops.)
€12k
▼ Sales (0 ops.)
—

Latest filing published 18 Nov 2024 for 博瑞医药.

程增江: trading record in brief

程增江 has a single filing on record, published on 18 November 2024: an open-market purchase of €12k in 博瑞医药. One trade is not enough to describe a pattern. These figures are compiled from regulatory filings published by SSE / SZSE (CSRC). They describe what insiders did and are not a recommendation.

Companies and markets linked to 程增江

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations1 total
  • ▲
    董事Executives博瑞医药
    7SSE
    3,000 sharesA股XSHGSSE:173000008276334900
    Canonical exit: 16 Feb 2025 (T+90)

1 of 1 declaration